Therapeuticsmd Inc
(TXMD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 49,647 | 16,100 | 16,778 | 19,357 | 20,143 |
| Cost of Goods | 6,335 | 2,738 | 2,637 | 4,186 | 4,507 |
| Gross Profit | 43,312 | 13,362 | 14,141 | 15,171 | 15,636 |
| Operating Expenses | 194,852 | 144,320 | 92,406 | 105,610 | 101,333 |
| Operating Income | -151,205 | -130,220 | -77,629 | -90,254 | -85,190 |
| Interest Expense | 17,382 | 4,678 | 0 | 0 | 0 |
| Other Income | -7,558 | 2,281 | 703 | 378 | 113 |
| Pre-tax Income | -176,145 | -132,617 | -76,925 | -89,876 | -85,077 |
| Net Income Continuous | -176,145 | -132,617 | -76,925 | -89,876 | -85,077 |
| Net Income | $-176,145 | $-132,617 | $-76,925 | $-89,876 | $-85,077 |
| EPS Basic Total Ops | -36.00 | -29.50 | -18.50 | -23.00 | -24.50 |
| EPS Basic Continuous Ops | -35.75 | -29.47 | -18.71 | -22.92 | -24.56 |
| EPS Diluted Total Ops | -36.00 | -29.50 | -18.50 | -23.00 | -24.50 |
| EPS Diluted Continuous Ops | -35.75 | -29.47 | -18.71 | -22.92 | -24.56 |
| EPS Diluted Before Non-Recurring Items | -34.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-149,813 | $-129,656 | $-77,416 | $-90,121 | $-85,128 |